Log in

FDA approves treatment for Alzheimer’s

By Deanna Chapman
Posted 7/7/21

The Alzheimer’s Association has announced the FDA approval of aducanumab (Aduhelm) —branded by Biogen— for the treatment of Alzheimer’s disease. Until now, there has not been any effective …

This item is available in full to subscribers.

Please log in to continue

Log in


X
X